Increased serum levels of soluble IL‐2 receptor, CD30 and CD8 molecules, and gamma‐interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms
- 1 August 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (4) , 485-488
- https://doi.org/10.1111/j.1365-2141.1990.tb07786.x
Abstract
Summary. Abnormal immunoreaction associated with increased cell activation phenomena might play a role in the pathogenetic events leading to the development of angioimmunoblastic lymphadenopathy (AILD). In the present study we investigated the serum levels of some soluble molecules related to cell activation in 24 patients with AILD at presentation. In particular, we measured by immunoenzymatic or immunoradiometric techniques the levels of the Tac peptide (sIL‐2R), soluble CD30 (sCD30) and CD8 (sCD8) antigens, and gamma‐IFN (gIFN). The results show that all the above molecules are increased as compared to normal controls, with a different pattern of increase for the different molecules. The sIL‐2R levels were very high in all cases with no overlap between AILD and control samples (mean 6315±3374 U/ml, controls 271±112 U/ml, PPP<0.01) was also observed with some overlap between AILD samples and controls.The above findings further support the view that a condition of abnormally enhanced cell activation is likely to play a central role in the pathogenetic events leading to the composite clinicopathological picture of AILD.This publication has 22 references indexed in Scilit:
- Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disordersClinical Immunology and Immunopathology, 1989
- Ki‐1 (CD30) antigen is released by Ki‐1‐positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki‐1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme‐linked immunosorbent assayEuropean Journal of Immunology, 1989
- Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritisJournal of Clinical Immunology, 1988
- Angioimmunoblastic Lymphadenopathy with DysproteinemiaAnnals of Internal Medicine, 1988
- THE SOLUBLE INTERLEUKIN‐2 RECEPTOR IN HAEMATOLOGICAL DISORDERSBritish Journal of Haematology, 1987
- The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic RetrovirusesAnnals of Internal Medicine, 1986
- Studies of the pathogenesis of angioimmunoblastic lymphadenopathy.Journal of Clinical Investigation, 1985
- Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders.Annals of the Rheumatic Diseases, 1983
- Angio-immunoblastic lymphadenopathyThe American Journal of Medicine, 1975
- Immunoblastic LymphadenopathyNew England Journal of Medicine, 1975